Latest Market News

FINEOS Corporation Holdings PLC reported a seasonal decline in cash balance and customer receipts in Q4 2024, while successfully onboarding new clients and maintaining a robust North American pipeline.

Australian Mines Limited reports a substantial increase in scandium mineral resources at its Flemington project and progresses its maiden drilling programs in Brazil, positioning itself for growth amid challenging nickel and cobalt markets.

EUROZ HARTLEYS GROUP LIMITED has announced a fully franked ordinary dividend of AUD 0.020 per share for the six months ending December 2024, signaling steady shareholder returns.

Euroz Hartleys Group reports a striking 501% jump in net profit for H1 FY2025, driven by strong capital raising and diversified revenue streams, prompting a dividend increase to 2 cents per share.

Energy Action Limited reports a strong positive operating cash flow of $1.08 million in Q2 FY25, boosted by customer receipts and an R&D tax rebate, while advancing its AI-driven energy platform Utilibox to fuel future growth.

Tissue Repair Limited has commenced patient randomisation in its Phase 3 trial of TR987®, targeting chronic venous leg ulcers, aiming to confirm promising earlier results and potentially transform wound healing treatment.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

Southern Hemisphere Mining Limited has reported a significant 15% extension to the Cerro-Ferro copper-gold system strike length, alongside promising drilling results that set the stage for a resource upgrade and deeper exploration in 2025.

JPMorgan Asset Management has announced estimated cash distributions for its suite of equity premium income ETFs for February 2025, providing investors with key dates and payout expectations.

Redivium's Q2 FY25 report reveals strategic progress in lithium-ion battery recycling across Europe, including new partnerships and feasibility studies, while navigating tight cash reserves and a critical entitlement offer.

Opyl Limited's Q2 FY25 update reveals robust progress through key partnerships, a new AI Biotech Fund launch, and strengthened financial footing, positioning the company for expanded influence in clinical trial optimisation.

ADX Energy Ltd's December quarter cash flow report reveals a $1.18 million net cash decrease from operations, with $9.08 million cash on hand and ongoing financing adjustments.